What is the treatment for thyroiditis (inflammation of the thyroid gland)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Thyroiditis treatment should be individualized based on the specific type and severity of the condition, with a focus on relieving symptoms, restoring normal thyroid function, and preventing complications, as evidenced by the USPSTF recommendation statement 1.

Treatment Approaches

  • For acute painful thyroiditis, nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen (400-800mg three times daily) or naproxen (250-500mg twice daily) are typically used for pain relief, as noted in the USPSTF recommendation statement 1.
  • In more severe cases, prednisone (20-40mg daily, tapered over 1-2 weeks) may be prescribed, although definitive data on its effectiveness are lacking 1.
  • Hashimoto's thyroiditis often requires lifelong levothyroxine replacement therapy, starting at 1.6 mcg/kg/day, with dose adjustments based on TSH levels, as recommended by the USPSTF 1.
  • Subacute thyroiditis may initially need only symptomatic treatment during the hyperthyroid phase, followed by beta-blockers like propranolol (10-40mg three times daily) to manage symptoms, as suggested by the USPSTF recommendation statement 1.
  • The hypothyroid phase might require temporary levothyroxine therapy, although the optimal duration and dosage are unclear 1.

Monitoring and Adjustment

  • Regular monitoring of thyroid function is essential for all types of thyroiditis to adjust treatment as needed, as emphasized by the USPSTF recommendation statement 1.
  • The goal of treatment is to restore normal thyroid function, relieve symptoms, and prevent complications, as thyroiditis involves inflammation of the thyroid gland that disrupts hormone production, as noted in the USPSTF recommendation statement 1.

From the Research

Thyroiditis Treatment Overview

  • Thyroiditis is a general term for inflammation of the thyroid gland, and its treatment depends on the specific type and symptoms 2.
  • The main goal of treatment is to relieve pain and control the inflammatory process, especially in subacute thyroiditis 3, 4.

Subacute Thyroiditis Treatment

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids are commonly used to treat subacute thyroiditis, with corticosteroids being more effective in achieving early clinical remission 3, 4.
  • Prednisolone treatment has been shown to be superior to NSAIDs in resolving symptoms, with a shorter time period for resolution of symptoms 4.
  • The total recurrence rate for subacute thyroiditis is around 19.8%, with recurrences being more frequent in patients receiving only steroid therapy 3.

Hashimoto Thyroiditis Treatment

  • Hashimoto thyroiditis is an autoimmune disorder that presents with or without signs or symptoms of hypothyroidism, and patients with overt hypothyroidism are generally treated with lifelong thyroid hormone therapy 2, 5.
  • Painful Hashimoto thyroiditis is a rare diagnosis, and optimal treatment remains unclear, but low-dose oral prednisone and intrathyroidal corticosteroid injection have shown favorable outcomes 6.
  • Total thyroidectomy has been shown to yield 100% sustained pain resolution in cases of painful Hashimoto thyroiditis 6.

Postpartum Thyroiditis Treatment

  • Postpartum thyroiditis occurs within one year of delivery, miscarriage, or medical abortion, and treatment focuses on symptoms, with beta blockers used to treat adrenergic symptoms in the hyperthyroid phase and levothyroxine used in the hypothyroid phase 2, 5.
  • Patients with postpartum thyroiditis should be monitored for changes in thyroid function, and treatment with levothyroxine should be considered in women with a serum thyroid-stimulating hormone level greater than 10 mIU per L, or in women with a thyroid-stimulating hormone level of 4 to 10 mIU per L who are symptomatic or desire fertility 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.